Elanco Animal Health Incorporated vs Johnson & Johnson
ELAN vs JNJ — side-by-side comparison from reported financials. ELAN leads 1, JNJ leads 8 of 9 comparable metrics.
Elanco Animal Health Incorporated
ELAN · Healthcare
$22.92+1.69%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | ELAN | JNJ |
|---|---|---|
| Price | $22.92 | $261.79 |
| Market cap | $11.4B | $631B |
| Revenue (TTM) | $5.02B | $97.9B |
| Revenue growth | +2.3% | +5.6% |
| Net margin | -4.0% | 21.5% |
| Free cash flow | $379M | $22.2B |
| Net cash (debt) | ($3.47B) | ($27.8B) |
| 1-year price return | +14.2% | +37.0% |
| P/E | — | 29.9 |
| P/E vs own history (cheap-side %) | 14% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | -3% | 26% |
| Altman Z-score | 1.23 | — |
| CV checks passed | 3 of 9 | 10 of 9 |
| Employees | 9,900 | 140,800 |
Full résumé-style profiles: ELAN CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.